EUVIMEDObjevte EUVIMED
Crossref

Cholesterol modulates trafficking of galanin receptor subtype 1 but not subtype 2: Insights from live‐cell imaging

Tianyi Li iD, Vladana Vukojević iD, Sho Oasa iD, Yunfei Bai iD, Yutao Yang iD, Hui Li, Yi Tang, Lars Terenius iD, Tomas Hökfelt iD, Per Svenningsson iD, Zhi-Qing David Xu iD

British Journal of Pharmacology · 2026

DOI: 10.1111/bph.70192 ↗

At a glance

Journal article in British Journal of Pharmacology, 2026. Written by Tianyi Li and 10 co-authors. Institution: Department of Neurobiology, Beijing Key Laboratory of Neural Regeneration and Repair, Capital Medical University, Beijing, China. Major MEDLINE topics: Cholesterol, Receptor, Galanin, Type 2, Receptor, Galanin, Type 1. 73 references. Funded by: Swedish Research Council, Swedish Foundation for International Cooperation in Research and Higher Education, National Natural Sciences Foundation of China.

AbstraktSubjectsBibliografické údajeCiteRelated studies

Abstract (original language)

Background and Purpose Galanin receptor subtype 1 (GALR1) and subtype 2 (GALR2) are G protein‐coupled receptors (GPCRs) that mediate galanin's diverse physiological roles, including neurotransmission and neuronal modulation. Although both receptors share functional similarities, they exhibit distinct differences in signalling pathways. Whilst previous studies have focussed on galanin binding and G‐protein selectivity, the role of plasma membrane‐specific mechanisms, particularly cholesterol depletion's influence, remains unclear. This study investigates cholesterol's role in regulating trafficking of GALR1 and GALR2 and their function in live cells. Experimental Approach We employed real‐time fluorescence techniques—Fluorescence Correlation Spectroscopy (FCS), Fluorescence Cross‐Correlation Spectroscopy (FCCS), and Fluorescence Recovery After Photobleaching (FRAP)—to assess receptor‐ligand interactions and lateral mobility in PC12 cells expressing EGFP‐tagged GALR1 or GALR2. Key Results Both receptors were co‐localised, co‐trafficked and internalised with galanin, with receptor‐peptide complexes dissociating prior to lysosomal degradation. Cholesterol selectively restricted GALR1's lateral diffusion and enhanced galanin binding and complex formation, whereas GALR2 remained unaffected. Interestingly, galanin binding relieved GALR1 from cholesterol‐mediated restriction, increasing receptor mobility and suggesting a dynamic, cholesterol‐dependent regulatory mechanism. Conclusions and Implications Cholesterol selectively modulates GALR1 trafficking and ligand interactions, whereas GALR2 operates independently of cholesterol, revealing distinct regulatory mechanisms for each receptor subtype. These findings provide new insights into the interplay between membrane composition and receptor function, with potential implications for developing targeted therapies for galanin‐related disorders.

Subjects

MeSH terms (MEDLINE)

CholesterolReceptor, Galanin, Type 2Receptor, Galanin, Type 1AnimalsPC12 CellsRatsProtein TransportGalanin

Author keywords

GPCRcholesterolfluorescence cross‐correlation spectroscopyfluorescence recovery after photobleachinggalaninmembrane microdomainsneuropeptides

Substances

CholesterolReceptor, Galanin, Type 2GalaninReceptor, Galanin, Type 1

Authors and institutions

  • Department of Neurobiology, Beijing Key Laboratory of Neural Regeneration and Repair, Capital Medical University, Beijing, China.
  • Laboratory of Translational Neuropharmacology, Department of Clinical Neuroscience, Center for Molecular Medicine L8:01, Karolinska University Hospital, Stockholm, Sweden.
  • Beijing Institute of Brain Disorders, Collaborative Innovation Center for Brain Disorders, Capital Medical University, Beijing, China.
  • Laboratory of Experimental Alcohol and Drug Addiction Research, Department of Clinical Neuroscience, Center for Molecular Medicine L8:01, Karolinska Institutet, Stockholm, Sweden.
  • Innovation Center for Neurological Disorders, Department of Neurology, National Center for Neurological Disorders, Xuanwu Hospital, Capital Medical University, Beijing, China.
  • Department of Neuroscience, Karolinska Institutet, Stockholm, Sweden.

ORCID profiles: Tianyi Li, Vladana Vukojević, Sho Oasa, Yunfei Bai, Yutao Yang, Lars Terenius, Tomas Hökfelt, Per Svenningsson, Zhi-Qing David Xu

Funding

  • Swedish Research Council
  • Swedish Foundation for International Cooperation in Research and Higher Education
  • National Natural Sciences Foundation of China
  • Key Project of Science and Technology Plan of Beijing Municipal Education Commission
  • Beijing Municipal Science and Technology Commission
  • The Arvid Carlsson Foundation

Cite

APA

Li, T., Vukojević, V., Oasa, S., Bai, Y., Yang, Y., Li, H., Tang, Y., Terenius, L., Hökfelt, T., Svenningsson, P., & Xu, Z. D. (2026). Cholesterol modulates trafficking of galanin receptor subtype 1 but not subtype 2: Insights from live‐cell imaging. British Journal of Pharmacology. https://doi.org/10.1111/bph.70192

Vancouver

Li T, Vukojević V, Oasa S, Bai Y, Yang Y, Li H, et al. Cholesterol modulates trafficking of galanin receptor subtype 1 but not subtype 2: Insights from live‐cell imaging. British Journal of Pharmacology. 2026. doi:10.1111/bph.70192

BibTeX
@article{Li2026,
  author = {Li, Tianyi and Vukojević, Vladana and Oasa, Sho and Bai, Yunfei and Yang, Yutao and Li, Hui and Tang, Yi and Terenius, Lars and Hökfelt, Tomas and Svenningsson, Per and Xu, Zhi-Qing David},
  title = {Cholesterol modulates trafficking of galanin receptor subtype 1 but not subtype 2: Insights from live‐cell imaging},
  journal = {British Journal of Pharmacology},
  year = {2026},
  doi = {10.1111/bph.70192}
}
Start for free →